CareMax — Q2 2022 Earnings Presentation
12 slides from CareMax's earnings presentation, Aug 9, 2022
Slide 1: Second Quarter 2022 Earnings Presentation
Second Quarter 2022 Earnings Presentation August 9, 2022 EX-99.2
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax at a Glance
CareMax at a Glance 37K Medicare Advantage Members 2011 Year Founded 51 Medical Centers1 100+ Employed Providers 88K Total Members We are… A founder-led, technology-enabled, whole person healthcare platform providing value-based care and chronic disease management to seniors. Our mission… Is to empo
Slide 4: Second Quarter 2022 Update
Second Quarter 2022 Update Reported revenue of $172 million for 2Q22, of which ~95% was risk-based revenue Achieved a 73.6% Medical Expense Ratio1 Medicare Advantage membership of 37,000, up 72% year-over-year Strong patient engagement evidenced by 88% of members seen by their primary care physician
Slide 5: We Expect Continued Growth in Our Center Footprint and Medicare Advantage Membership
We Expect Continued Growth in Our Center Footprint and Medicare Advantage Membership Centers Medicare Advantage Members 10x >13x 2021 2017 2019 2018 2020 2022E 60 >40,000 2017 2022E 2018 2019 2020 2021 2Q22 YE22 2Q22 YE22
Slide 6: Updating Financial Outlook for Full Year 2022
Updating Financial Outlook for Full Year 2022 FY 2022 Previous Guidance FY 2022 Updated Guidance YoY % growth Medicare Advantage Membership 38,000 to 40,000 Greater than 40,000 >19% Revenue $540 million to $560 million $580 million to $600 million 44% to 49%1 Adjusted EBITDA $30 million to $40 milli
Slide 7: Second Quarter 2022 Financial Supplement
Second Quarter 2022 Financial Supplement
Slide 8: Reconciliation to Non-GAAP Financial Metrics
Reconciliation to Non-GAAP Financial Metrics 2Q22 Non-GAAP Reconciliation 2Q21 Non-GAAP Reconciliation Reflects impact of business combination of CareMax, IMC Medical Group Holdings, and Care Holdings and other pro forma adjustments as may arise from the combination.
Slide 9: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA Note: Pro forma and non-GAAP figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods (the “Business Combination”). Totals may not sum due to rounding. Pro forma net income replaces historical interest
Slide 10: Historical Non-GAAP Financial Summary
Historical Non-GAAP Financial Summary Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Includes operating losses incurred by de novo centers up to 18 months after opening. Non-GAAP Inco
Slide 11: Capitalization and Liquidity
Capitalization and Liquidity Excludes unvested warrants as of June 30, 2022. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money based on CareMax’s closing share price as of August 5, 2022.
Slide 12: Q&A
Caremax Q&A